# Task 1.1 - Revenue Discrepancy Fix - COMPLETED

## Issue
**Dashboard IV Therapy Revenue**: $15,060.60  
**Expected from File (Jan 5-11, 2026)**: $16,459.20  
**Discrepancy**: -$1,398.60 (missing revenue)

## Root Cause Identified
The revenue calculation in `server.js` only counted visits that had a **base infusion service** (Hydration, Energy, Immunity, etc.). This excluded:

### Missing Service Types:
1. **Standalone add-ons without base infusion**
   - NAD 250mg (Member) — $650.00
   - NAD 200mg (Non Member) — $535.50
   - HD Vitamin C - 50g — $318.75
   - Vitamin D3 Injection (Non-Member) — $112.00

2. **Standalone injections**
   - Xeomin Neurotoxin — $350.00
   - B12 injections, Glutathione injections, etc.

3. **Other IV-related services**
   - Micronutrient Labs — $475.00 (when not admin-only)
   - Hormones - Initial Visit — $147.00 (when not hormone-only)

## Solution Implemented

### Code Changes (`server.js` lines 1939-2027)

**New Logic:**
```javascript
// Determine if visit is IV therapy
isIVTherapyVisit = hasBaseInfusion || hasStandaloneInjection

// If no base or injection, check for add-ons
if (!isIVTherapyVisit) {
  hasIVAddon = services has NAD, Vitamin C, etc.
  hasWeightLoss = services has semaglutide, tirzepatide
  hasHormone = services has hormone therapy
  hasAdminOnly = all services are membership/labs/admin
  
  // Include add-ons if NOT exclusively admin/weight loss/hormone
  if (hasIVAddon && !hasWeightLoss && !hasHormone && !hasAdminOnly) {
    isIVTherapyVisit = true
  }
}

// Add revenue ONCE for all IV therapy visits (prevents double-counting)
if (isIVTherapyVisit) {
  infusionWeeklyRevenue += totalAmount
}
```

### Key Improvements:
1. ✅ **Includes standalone add-ons** (NAD, Vitamin C, etc.) in IV therapy revenue
2. ✅ **Includes standalone injections** (Xeomin, B12, etc.) in IV therapy revenue
3. ✅ **Prevents double-counting** by consolidating revenue addition to single location
4. ✅ **Properly excludes** weight loss, membership, hormone, and lab-only services
5. ✅ **Maintains separate injection tracking** for reporting purposes

## Expected Results After Deployment

### For Jan 5-11, 2026:
- **Previous IV Therapy**: $15,060.60
- **Expected IV Therapy**: ~$16,459.20
- **Improvement**: +$1,398.60

### Revenue Categories (Post-Fix):
- **IV Therapy**: Base infusions + add-ons + standalone injections
- **Weight Loss**: Semaglutide, Tirzepatide, Contrave (unchanged)
- **Membership**: Membership fees, admin-only visits (unchanged)
- **Hormone**: Hormone therapy services (unchanged)

## Deployment Status
✅ **Committed**: Changes committed to git  
✅ **Pushed**: Pushed to GitHub (main branch)  
🚀 **Railway**: Automatic redeployment triggered

## Verification Steps (After Deployment)
1. Upload the Jan 5-11, 2026 file to the dashboard
2. Verify IV Therapy revenue shows ~$16,459.20 (instead of $15,060.60)
3. Verify Total Weekly Actual is accurate
4. Check that Weight Loss, Membership, and other categories remain correct
5. Confirm no double-counting occurred

## Additional Notes

### Total Revenue Discrepancy ($146.70)
The dashboard shows **$30,905.82** vs. file total **$30,759.12** (+$146.70).

This could be due to:
- Data already in database from previous uploads
- Different week range interpretation
- Needs separate investigation if persists after fix

### Files Modified:
- `server.js` - Revenue calculation logic (lines 1939-2027)
- `REVENUE_FIX_JAN_5_11.md` - Detailed technical documentation
- `diagnose-jan-5-11.js` - Diagnostic script (created for analysis)

## Next Steps
1. ✅ Monitor Railway deployment logs
2. ⏳ Test with Jan 5-11, 2026 data after deployment
3. ⏳ Verify revenue accuracy across all categories
4. ⏳ Investigate $146.70 total discrepancy if it persists

---
**Completed**: January 21, 2026  
**Deployed**: Railway automatic deployment in progress
